TEVA director exercises 14,492 share units
TEVA PHARMACEUTICAL INDUSTRIES LTD director Amir Elstein exercised restricted share units into ordinary shares.
Rhea-AI Filing Summary
TEVA PHARMACEUTICAL INDUSTRIES LTD director Amir Elstein exercised restricted share units into ordinary shares. On June 5, 2026, 14,492 restricted share units vested and were converted into 14,492 ordinary shares at a stated price of $0.00 per share.
After this non-cash equity compensation event, Elstein directly held 2,118,455 ordinary shares. Each restricted share unit provided a contingent right to receive one ordinary share or, at the company committee’s option, the cash value of one ordinary share. No open-market buy or sell transaction was reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Units | 14,492 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 14,492 | $0.00 | $0.00 |
Footnotes (3)
- F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- F3. Restricted share units were granted on June 5, 2025 and vested on June 5, 2026.
Key Figures
Key Terms
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TEVA director Amir Elstein report on this Form 4?
Does this TEVA Form 4 indicate any remaining derivative or RSU position for Amir Elstein?
AI-generated analysis. How Rhea-AI works. Not financial advice.